Cargando…
A critical review of brand and generic alendronate for the treatment of osteoporosis
OBJECTIVE: Compare in vitro and in vivo characteristics and clinical outcomes of brand and generic alendronate. Research design and methods: Relevant search terms were input into Medline ("alendronate" AND "generic" up to August 5, 2013) and any abstracts deemed possibly relevant...
Autores principales: | Brown, Jacques P, Davison, Kenneth S, Olszynski, Wojciech P, Beattie, Karen A, Adachi, Jonathan D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320211/ https://www.ncbi.nlm.nih.gov/pubmed/25674402 http://dx.doi.org/10.1186/2193-1801-2-550 |
Ejemplares similares
-
Differences in In Vitro Disintegration Time among Canadian Brand and Generic Bisphosphonates
por: Olszynski, Wojciech P., et al.
Publicado: (2014) -
Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax(®)) for osteoporosis treatment
por: Unnanuntana, Aasis, et al.
Publicado: (2017) -
Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study
por: Grima, Daniel T, et al.
Publicado: (2010) -
Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment
por: Nayak, Smita, et al.
Publicado: (2012) -
Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study
por: Li, Mei, et al.
Publicado: (2022)